Should You Buy Axalta Coating Systems Ltd. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Axalta Coating Systems Ltd. (AXTA) scores a robust 8.6/10 on our 32-signal Quality of Company framework. At the current market price of $33.29 and a $7.1B market cap, our analysis maps this fundamental strength against 13 institutional-grade models to determine if a sufficient margin of safety exists.
The short answer: 3 of 11 CirclFi valuation models project upside for Axalta Coating Systems Ltd. (AXTA) at $33.29 — the model consensus leans bearish, with a Quality Score of 8.6/10 and Value-Trap risk of 17/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Axalta Coating Systems Ltd. (AXTA) in 2026?
What Is the Bull Case vs the Bear Case for Axalta Coating Systems Ltd. (AXTA)?
| Bull case — $67.82 target (+103.7%) | Bear case — $5.80 target (-82.6%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Axalta Coating Systems Ltd.'s quality score of 8.6/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation. | According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model sees the stock as overvalued with a fair value of $5.80 (-82.6%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $67.82 (+103.7%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +186.3% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
| Industry tailwind: infrastructure spending cycle could provide meaningful support for Axalta Coating Systems Ltd.'s revenue and margin trajectory in the Specialty Chemicals space. | Industry headwind: end-market concentration risk represents a meaningful risk for Axalta Coating Systems Ltd. and its Specialty Chemicals peers. |
How Does AXTA Compare to Its Specialty Chemicals Peers?
Valuation data pages: PPG · CBT · ECL · ESI · IOSP · NTIC · ALB · CC · BIOF · ODC · RPM
Which Other Stocks Score Like AXTA on Quality?
Closest companies to AXTA’s Quality of Company score of 8.6/10, across all industries.
- RDVT — Red Violet, Inc. (QOC 8.6) · analysis
- FMX — Fomento Económico Mexicano, S.A.B. de C.V. (QOC 8.6) · analysis
- LVS — Las Vegas Sands Corp. (QOC 8.6) · analysis
- EVR — Evercore Inc. (QOC 8.6) · analysis
- IH — iHuman Inc. (QOC 8.6) · analysis
- ORI — Old Republic International Corporation (QOC 8.6) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Specialty Chemicals Screens Does AXTA Appear In?
So Is Axalta Coating Systems Ltd. (AXTA) Worth Buying in 2026?
Caution dominates our read on Axalta Coating Systems Ltd. at $33.29. 8 of 11 models see limited upside or outright downside, with the median fair value at $22.05 (-33.8%). Quality at 8.6/10 provides some fundamental cushion. Current holders should re-evaluate their thesis; new buyers should demand a wider margin of safety.
These are quantitative model outputs, not investment recommendations. Axalta Coating Systems Ltd.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About AXTA Stock?
Should I buy AXTA stock right now?
Based on CirclFi's multi-model analysis, 3 of 11 models see upside for AXTA at $33.29. The models are divided, which means the investment case depends heavily on your assumptions about Axalta Coating Systems Ltd.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Axalta Coating Systems Ltd.?
Key risks include: wide model disagreement (1068% spread), signaling high uncertainty; general market and sector-specific risks affecting Specialty Chemicals companies. Always diversify and consult a financial advisor.
How does AXTA compare to its competitors?
Among Specialty Chemicals peers, AXTA holds a Quality Score of 8.6/10. Comparable companies include PPG (QOC 8.7), CBT (QOC 8.6), ECL (QOC 8.7). The relative ranking helps investors identify whether AXTA offers better fundamental quality than alternatives in the same sector.
Is AXTA a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. AXTA's Quality Score of 8.6/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy AXTA at?
CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $5.80 to $67.82. At $33.29, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for AXTA.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad